PuSH - Publication Server of Helmholtz Zentrum München: Highlights from the 2023 international meeting on the molecular biology of hepatitis B virus.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

HBV2023* ; Allweiss, L.* ; Cohen, C.* ; Dias, J.M.L.* ; Fumagalli, V.* ; Guo, H.* ; Harris, J.M.* ; Hu, J.* ; Iannacone, M.* ; Isogawa, M.* ; Jeng, W.J.* ; Kim, K.H.* ; Kramvis, A.* ; Li, W.* ; Lucifora, J.* ; Muramatsu, M.* ; Neuveut, C.* ; Ploss, A.* ; Pollicino, T.* ; Protzer, U. ; Tan, A.* ; Tanaka, Y.* ; Tu, T.* ; Tsukuda, S.* ; Thimme, R.* ; Urban, S.* ; Watashi, K.* ; Yuan, Z.* ; Yeh, S.H.* ; McKeating, J.A.* ; Revill, P.A.*

Highlights from the 2023 international meeting on the molecular biology of hepatitis B virus.

J. Gen. Virol. 105:001978 (2024)

Publ. Version/Full Text

DOI

PMC

	Open Access Hybrid

Abstract
Metrics
Extra information

Since its discovery in 1965, our understanding of the hepatitis B virus (HBV) replication cycle and host immune responses has increased markedly. In contrast, our knowledge of the molecular biology of hepatitis delta virus (HDV), which is associated with more severe liver disease, is less well understood. Despite the progress made, critical gaps remain in our knowledge of HBV and HDV replication and the mechanisms underlying viral persistence and evasion of host immunity. The International HBV Meeting is the leading annual scientific meeting for presenting the latest advances in HBV and HDV molecular virology, immunology, and epidemiology. In 2023, the annual scientific meeting was held in Kobe, Japan and this review summarises some of the advances presented at the Meeting and lists gaps in our knowledge that may facilitate the development of new therapies.

Impact Factor

Scopus SNIP

Altmetric

3.600

0.000